Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Operations (2016 - 2025)

Phibro Animal Health has reported Cash from Operations over the past 13 years, most recently at 19352000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 19352000.0 for Q4 2025, up 529.13% from a year ago — trailing twelve months through Dec 2025 was 93080000.0 (up 67.61% YoY), and the annual figure for FY2025 was 80124000.0, down 8.53%.
  • Cash from Operations for Q4 2025 was 19352000.0 at Phibro Animal Health, up from 9302000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PAHC hit a ceiling of 43154000.0 in Q1 2025 and a floor of 10698000.0 in Q3 2022.
  • Median Cash from Operations over the past 5 years was 12015000.0 (2024), compared with a mean of 13051300.0.
  • Biggest five-year swings in Cash from Operations: crashed 379.98% in 2022 and later surged 1367.9% in 2023.
  • Phibro Animal Health's Cash from Operations stood at 20122000.0 in 2021, then plummeted by 112.37% to 2489000.0 in 2022, then surged by 1367.9% to 31558000.0 in 2023, then crashed by 90.25% to 3076000.0 in 2024, then surged by 529.13% to 19352000.0 in 2025.
  • The last three reported values for Cash from Operations were 19352000.0 (Q4 2025), 9302000.0 (Q3 2025), and 21272000.0 (Q2 2025) per Business Quant data.